CN110384794A - A kind of ointment for female vulva hickie - Google Patents

A kind of ointment for female vulva hickie Download PDF

Info

Publication number
CN110384794A
CN110384794A CN201810361770.7A CN201810361770A CN110384794A CN 110384794 A CN110384794 A CN 110384794A CN 201810361770 A CN201810361770 A CN 201810361770A CN 110384794 A CN110384794 A CN 110384794A
Authority
CN
China
Prior art keywords
hickie
ointment
vulva
female vulva
bamboo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810361770.7A
Other languages
Chinese (zh)
Inventor
杜阳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
XI'AN WANHE PHARMACEUTICAL CO Ltd
Original Assignee
XI'AN WANHE PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by XI'AN WANHE PHARMACEUTICAL CO Ltd filed Critical XI'AN WANHE PHARMACEUTICAL CO Ltd
Priority to CN201810361770.7A priority Critical patent/CN110384794A/en
Publication of CN110384794A publication Critical patent/CN110384794A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • A61K35/644Beeswax; Propolis; Royal jelly; Honey
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • A61K36/066Clavicipitaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/234Cnidium (snowparsley)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489Sophora, e.g. necklacepod or mamani
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Abstract

The present invention provides a kind of ointment for female vulva hickie, it is made of the raw material of following weight ratio: the red bacterium of bamboo, frutus cnidii, kuh-seng, propolis, acetic acid chlorhexidine, biologically active peptide, after product of the invention is applied to female vulva, it can go deep into skin texture rapidly, it is effectively antipruritic, destroy the living environment of harmful bacteria, improve antibacterial ability, and Chinese medicine combination drug effect is mildly non-stimulated, patient is after using 7 days, the vulva surface surface of a wound starts to heal, and pigment starts to precipitate after 10-15 days, and hickie illness is eased.

Description

A kind of ointment for female vulva hickie
Technical field
The invention belongs to technical field of traditional Chinese medicines, and in particular to a kind of ointment for female vulva hickie.
Background technique
Female vulva hickie is also known as that vulva white is damaged or dystrophy of vulva, nosogenesis be vulva local nerve with Lesion tissue caused by angiodystrophia and pigment alteration, clinically by external cause local skin and mucous membrane denaturation or atrophic disease Disease is referred to as leukoplakia vulvae.Unbearably for pudendal pruritus, local skin is dry for the Symptoms of leukoplakia vulvae, bleaches and plump, has Pain burning sensation.It is clinically laser, the methods of microwave, but the method only acts on to the traditional therapy of leukoplakia vulvae Skin surface is unable to reach the purpose of radical cure, also has high energy to gather ultrasound, local block therapy etc. at present and takes effect apparent therapy, But such therapy medication is all hormone medicine, patient is very careful to the selection of hormone medicine therefore this in recent years Method is not appropriate for being used for a long time.At present to the treatment of leukoplakia vulvae in addition to there are also the methods of medications for surgical treatment, still Long-term stubborn disease this for leukoplakia vulvae, the effect is unsatisfactory, ailing to torment patient throughout the year.
Summary of the invention
According to above-mentioned elaboration, the purpose of the present invention is to provide a kind of Chinese medicine composition sprays, are used for female vulva hickie Treatment.
Technical solution provided by the invention: a kind of ointment for female vulva hickie is the raw material by following weight ratio It is made: the red bacterium 15%~20% of bamboo, frutus cnidii 3%~5%, propolis 1%~3%, kuh-seng 1%~3%, acetic acid chlorhexidine 0.20-0.40%, biologically active peptide 1%~3%.
In above-mentioned technical proposal, the red bacterium 20% of bamboo, kuh-seng 1%, frutus cnidii 3%, propolis 1%, acetic acid chlorhexidine 0.30%, Biologically active peptide 1%.
A kind of preparation method of ointment for female vulva hickie provided by the invention is: by the raw material: The red bacterium of bamboo, frutus cnidii, propolis, kuh-seng, acetic acid chlorhexidine, biologically active peptide mix lotion.
The extraction of Chinese medicine uses aqueous solvent extracting mode, the effective component of extraction.
For the present invention based on pathogenesis and treatment principle to female vulva disease, compatibility is reasonable, scientific, is largely faced Bed verifying, without any toxicity and side effects, after product of the invention is applied to female vulva, can go deep into rapidly skin texture, and effectively antipruritic, destruction has The living environment of evil bacterium, improves antibacterial ability, and Chinese medicine combination drug effect is mildly non-stimulated, and patient is after using 7 days, vulva The surface surface of a wound starts to heal, and pigment starts to precipitate after 10-15 days, and hickie illness is eased.
Specific embodiment
Technical solution of the present invention is clearly and completely described below, it is clear that described embodiment is only this Invention a part of the embodiment, instead of all the embodiments.Based on the embodiments of the present invention, those of ordinary skill in the art exist Every other embodiment obtained under the premise of creative work is not made, shall fall within the protection scope of the present invention.
Compatibility of drugs of the invention is reasonable, and component effect is:
The red bacterium of bamboo, property is pungent, puckery, puts down.Enter Liver Channel.There are detoxifying and relieving itching, torr sore myogenic.
Kuh-seng, bitter is cold in nature, return heart, liver, stomach, large intestine, bladder meridian, has heat-clearing, eliminating dampness, and the effect of desinsection has only negative The benefits of itching.
Propolis has the effect of moisturizing myogenic, anti-inflammatory analgetic.
Frutus cnidii, warm-natured, bitter return kidney channel, and the present invention utilizes antibacterial, antimycotic, anti-inflammatory effect.
Acetic acid chlorhexidine plays bactericidal effect.
Biologically active peptide adjusts the physiological function of internal cell, activates related enzyme system in vivo, promotes the logical of intermediate supersession film The effect of permeability.
According to above-mentioned component and compatibility principle analysis, the present invention, following embodiment is disclosed.
Embodiment:
Take: a kind of ointment for female vulva hickie, is to be made from the following raw materials in parts by weight:
The frutus cnidii that bamboo parasitic fungus extract 200g that hypocrellin effective content is 20%, frutus cnidii effective content are 10% The propolis extract that shrubby sophora extract 10g that extract 30g, matrine effective content are 98%, propolis effective content are 10% 10g, acetic acid chlorhexidine 0.3g, biologically active peptide 10g are stirred evenly, and the last weight of mixture is 260.3g.
In use, Chinese medicine composition lotion is uniformly applied to female vulva affected part surface by patient.
To show fungistatic effect of the invention, the embodiment of the present invention does bacteriostatic test:
One, equipment
1, test strain: Escherichia coli (8099) are cultivated 9 generations, Candida albicans (ATCC10231), culture 9 generations, golden yellow Color staphylococcus (ATCC6538) cultivated for 9 generations, is provided by Chinese Culture Collection Center.
2, general English agar medium, sabouraud's agar are provided by Beijing road and bridge technology Co., Ltd.
3/0.03mol/L phosphate buffer solution (PBS)
4, carrier: filter paper (2.0cm × 3.0cm), sterile measuring pipette, sterilized petri dishes, sterile test tube, constant incubator Deng
Two, sample is the present embodiment 5g, is put into sterile mortar grinding, crushes, mixes, is put into sterilized petri dishes and is directly pressed down Bacterium test.
Three, method is according to GB15979-200 " Disposable Sanitary Accessory sanitary standard " appendix C 4, " disinfection technology rule Model " 2002 editions 2.1.8 test.
Bacteriostatic test is carrier test, and 20 DEG C ± 1 DEG C of test temperature, test is repeated 3 times.
Four, result
Under conditions of 20 DEG C ± 2 DEG C of test temperature, embodiment is to Escherichia coli, Candida albicans, Staphylococcus aureus Bacterium inhibitory effect.
The embodiment of the present invention is shown in Table 1 to the inhibitory effect inspection of staphylococcus aureus;
The inhibitory effect of 1 staphylococcus aureus of table
The embodiment of the present invention is shown in Table 2 for the inhibitory effect inspection of Candida albicans.
The inhibitory effect of 2 Candida albicans of table
The embodiment of the present invention is shown in Table 3 to the inhibitory effect inspection of Escherichia coli;
The inhibitory effect of 3 Escherichia coli of table
The conclusion tested above, for embodiment to Escherichia coli, Candida albicans, staphylococcus aureus inhibiting rate are reachable 90% or more.
To show clinical application effect of the invention, the present invention is proved through clinical and experimental study: to the composition of embodiment Crowd through age groups carries out test effect, and through testing, this product has good effect to female vulva hickie, such as suffers from 7 days beginning vulva surface of a wound start to heal person after use, and there are vulvas to have the symptoms such as itch, pain calcination equal before use by patient It obtains biggish improvement after using 10-15 days, when use after cleaning vulva, this product is taken uniformly to be applied to uncomfortable position.Daily 1-2 times.
The above description is merely a specific embodiment, but scope of protection of the present invention is not limited thereto, any Those familiar with the art in the technical scope disclosed by the present invention, can easily think of the change or the replacement, and should all contain Lid is within protection scope of the present invention.Therefore, the protection scope of the present invention shall be subject to the protection scope of the claims.

Claims (3)

1. a kind of ointment for female vulva hickie, it is characterised in that: be made of the raw material of following weight ratio: the red bacterium of bamboo 15%~20%, frutus cnidii 3%~5%, propolis 1%~3%, kuh-seng 1%~3%, acetic acid chlorhexidine 0.20-0.40%, life Object active peptide 1%~3%.
2. a kind of ointment for female vulva hickie according to claim 1, it is characterised in that: be by following weight ratio Raw material be made: the red bacterium 20% of bamboo, kuh-seng 1%, frutus cnidii 3%, propolis 1%, acetic acid chlorhexidine 0.30%, biologically active peptide 1%, the red bacterium of the raw material bamboo, frutus cnidii, acetic acid chlorhexidine mix with the kuh-seng of equivalent weight, biologically active peptide.
3. a kind of ointment for female vulva hickie according to claims 1 and 2, it is characterised in that: the ointment system Preparation Method is that the red bacterium of bamboo, frutus cnidii, kuh-seng, acetic acid chlorhexidine, biologically active peptide is taken to pulverize using grinder, and bee is added Lotion is made in glue.
CN201810361770.7A 2018-04-20 2018-04-20 A kind of ointment for female vulva hickie Pending CN110384794A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810361770.7A CN110384794A (en) 2018-04-20 2018-04-20 A kind of ointment for female vulva hickie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810361770.7A CN110384794A (en) 2018-04-20 2018-04-20 A kind of ointment for female vulva hickie

Publications (1)

Publication Number Publication Date
CN110384794A true CN110384794A (en) 2019-10-29

Family

ID=68283669

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810361770.7A Pending CN110384794A (en) 2018-04-20 2018-04-20 A kind of ointment for female vulva hickie

Country Status (1)

Country Link
CN (1) CN110384794A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1284494A (en) * 2000-08-22 2001-02-21 云南医药工业股份有限公司 Bamboo parasitic fungus extract and its preparation and application
CN101991605A (en) * 2010-11-12 2011-03-30 杨长辉 Medicament for bactriostasis, protection and cleaning of vagina of human body and preparation method thereof
CN107510768A (en) * 2016-06-15 2017-12-26 吴鹏飞 A kind of draft bacteriostatic gel
CN107802825A (en) * 2017-12-04 2018-03-16 陕西美芙康生物科技有限公司 A kind of Traditional Chinese medicine gel composition antibacterial for vaginal mucosa
CN107812137A (en) * 2017-10-25 2018-03-20 北京中蜜科技发展有限公司 A kind of draft skin bacteriostatic gel of propolis-containing and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1284494A (en) * 2000-08-22 2001-02-21 云南医药工业股份有限公司 Bamboo parasitic fungus extract and its preparation and application
CN101991605A (en) * 2010-11-12 2011-03-30 杨长辉 Medicament for bactriostasis, protection and cleaning of vagina of human body and preparation method thereof
CN107510768A (en) * 2016-06-15 2017-12-26 吴鹏飞 A kind of draft bacteriostatic gel
CN107812137A (en) * 2017-10-25 2018-03-20 北京中蜜科技发展有限公司 A kind of draft skin bacteriostatic gel of propolis-containing and preparation method thereof
CN107802825A (en) * 2017-12-04 2018-03-16 陕西美芙康生物科技有限公司 A kind of Traditional Chinese medicine gel composition antibacterial for vaginal mucosa

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
张胜泉,等: "竹红菌治疗外阴白色病变(白斑)的组织变化研究―附13例治疗前后的组织学观查", 《云南医药》 *
顾红媛: "竹红菌素软膏治疗外阴白斑病33例疗效观察", 《中国伤残医学》 *
颜世明,等,主编,: "《美容与皮肤病外用妙方集》", 31 May 1995, 南京大学出版社 *

Similar Documents

Publication Publication Date Title
CN109568206B (en) Special antibacterial composition and lotion for women and preparation method thereof
CN109125706A (en) A kind of peptide composition for being effectively improved acne and repairing skin lesion
CN107802825A (en) A kind of Traditional Chinese medicine gel composition antibacterial for vaginal mucosa
CN110876760B (en) Skin external composition with wound healing promoting and/or scar repairing effects
CN108096396A (en) A kind of Traditional Chinese medicine gel composition antibacterial for vaginal mucosa
CN109010526A (en) One kind is for the antibacterial clean Traditional Chinese medicine gel composition of maintenance of vaginal mucosa
CN107519236A (en) A kind of topical agent for treating onychomycosis
CN109010529A (en) A kind of Traditional Chinese medicine bacteriostatic gelling agent for vagina nursing
CN105854021A (en) External-use drug and preparation with analgesic and antibacterial effect and preparation method thereof
CN105943666B (en) Composition for nursing sensitive skin of infant and preparation method thereof
US6992073B2 (en) Use of N-acetyl-D-glucosamine in the manufacture of a medicament for treating cervical erosion
US20040109899A1 (en) Antiviral medicament and method for producing and using the same for the prophylactic and therapeutic treatment of papillomavirus induced tumors, lesions and deseases
CN103071058A (en) Dendrobe extract and application of dendrobe extract
CN103432049B (en) Composition with deodorization function
CN109602813A (en) A kind of bacteriostatic gel and preparation method thereof
CN105613612A (en) Agent for disinfecting intensive care unit and preparation method
CN110384794A (en) A kind of ointment for female vulva hickie
CN100569277C (en) A kind of effervescent tablet for the treatment of female vagina and its production and use
CN103007034A (en) Traditional Chinese medicine composition used for treatment of residual second-degree burn wound, and preparation method thereof
CN101461850B (en) Application of Chinese medicinal composition in preparing medicament for treating acne
CN108066518A (en) A kind of dog Chinese medicine bath lotion composition and preparation method thereof
CN104257913A (en) Traditional Chinese medicine concentrated solution for treating cow mastitis and coating agent prepared from concentrated solution
CN104083406A (en) Compound disinfectant and preparation method thereof
CN108379327A (en) A kind of anaesthetic and its preparation process for treating nose-nasosinusitis
CN1462584A (en) Externally-used disinfector

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20191029